Product Information
ORACIT ORAL SOLUTION is a generic product labeled by CMP Pharma, Inc., priced at $0.0713 per ML under NDC 46287001401. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
640; 490 mg/5mL; mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287001401
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATEApproval Type
Unapproved
On Market Since
5/15/1984
Pharmacological Classes
Price Statistics
The NADAC for ORACIT ORAL SOLUTION has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0713 per ML |
|---|---|
| All-time high | $0.0809 (Feb 12, 2025) |
| All-time low | $0.0713 (Jun 17, 2026) |
| 52-week high | $0.0779 |
| 52-week low | $0.0713 |
| Median price | $0.0760 |
| Average price | $0.0761 |
| Largest weekly change | +2.5% (Aug 20, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Citric Acid and Sodium Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ORACIT ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ORACIT ORAL SOLUTION, manufactured by CMP Pharma, Inc., is $0.0713 per ML (NDC 46287001401), effective Jun 24, 2026.
How has the price of ORACIT ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for ORACIT ORAL SOLUTION has declined 11.7%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for ORACIT ORAL SOLUTION?
Since Dec 18, 2024, the NADAC for ORACIT ORAL SOLUTION has ranged from a low of $0.0713 (Jun 17, 2026) to a high of $0.0809 (Feb 12, 2025), with a median of $0.0760 per ML.
Are there cheaper alternatives to ORACIT ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ORACIT ORAL SOLUTION, so no direct lower-cost alternative is listed.
Who manufactures ORACIT ORAL SOLUTION?
ORACIT ORAL SOLUTION (NDC 46287001401) is labeled by CMP Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification